CN Patent

CN113423400A — 用于治疗或预防头痛的组合物、装置和方法

Assigned to Little Tangerine Pharmaceutical Co · Expires 2021-09-21 · 5y expired

What this patent protects

本文公开了药物组合物、装置、其组合及其在例如治疗或预防头痛中的用途。本公开内容提供了医学治疗或预防(例如，头痛)的新方法，与常规方法相比，产生了出乎意料的优异药代动力学。在一些情况下，本文的方法可以产生代谢物的独特药代动力学特征。

USPTO Abstract

本文公开了药物组合物、装置、其组合及其在例如治疗或预防头痛中的用途。本公开内容提供了医学治疗或预防(例如，头痛)的新方法，与常规方法相比，产生了出乎意料的优异药代动力学。在一些情况下，本文的方法可以产生代谢物的独特药代动力学特征。

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: CN113423400A
Jurisdiction: CN
Classification: —
Expires: 2021-09-21
Drug substance claim: No
Drug product claim: No
Assignee: Little Tangerine Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.